AlzeCure Pharma AB (AC6) Stock Price & News

All values in SEK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	97.33M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	7.71M	16.11M	20.68M	15.96M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.36M	2.91M	3.34M	4.42M
Operating expense	10.05M	18.05M	21.77M	17.09M
Total operating expenses	10.05M	18.05M	21.77M	17.09M
Operating income	-10.05M	-18.05M	-21.77M	80.23M
Other non operating income	-	-	-	-
EBT including unusual items	-10.03M	-17.75M	-21.70M	80.18M
EBT excluding unusual items	-10.03M	-17.75M	-21.70M	80.18M
Income tax expense	-4.00K	-4.00K	-2.00K	-1.00K
Effective tax rate	0.04%	0.02%	0.01%	-
Other operating expenses	-15.00K	-971.00K	-2.25M	-3.29M
Net income	-10.02M	-17.74M	-21.70M	80.18M
Net profit margin	-	-	-	82.38%
Earnings per share	-	-	-	-
Interest and investment income	102.00K	194.00K	143.00K	69.00K
Interest expense	-66.00K	-62.00K	-58.00K	-54.00K
Net interest expenses	36.00K	132.00K	85.00K	15.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-9.74M	-17.75M	-21.47M	80.53M
Gain or loss from assets sale	-	-	-	-

Finance